Altered SWD stopping mechanism in WAG/Rij rats subchronically treated with the cannabinoid agonist R(+)WIN55,212-2 (Q92121452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

title

Altered SWD stopping mechanism in WAG/Rij rats subchronically treated with the cannabinoid agonist R(+)WIN55,212-2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Martin F J Perescis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Nienke A R Flipsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Gilles van Luijtelaar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Clementina M van Rijn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

publication date

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

106722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

The molecular logic of endocannabinoid signalling

27 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

More surprises lying ahead. The endocannabinoids keep us guessing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

The Role of the Endocannabinoid System in the Brain-Gut Axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Endocannabinoid system: Role in depression, reward and pain control (Review).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cannabinoid receptor localization in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

WAG/Rij rats show a reduced expression of CB₁ receptors in thalamic nuclei and respond to the CB₁ receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Role of endogenous cannabinoids in synaptic signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

The future of endocannabinoid-oriented clinical research after CB1 antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Molecular model of cannabis sensitivity in developing neuronal circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

The role of α₂-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

EEG spectral analysis for the evaluation of the central effects of ?6-tetrahydrocannabinol in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Endocannabinoid system protects against cryptogenic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Pro-epileptic effects of the cannabinoid receptor antagonist SR141716 in a model of audiogenic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Modulation of pilocarpine-induced seizures by cannabinoid receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Rimonabant induces partial seizures in a patient with a history of generalized epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cannabis use and the development of tolerance: a systematic review of human evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Sex, THC, and hormones: Effects on density and sensitivity of CB cannabinoid receptors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Starting and stopping mechanisms of absence epileptic seizures are revealed by hazard functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Neonatal exposure to AY-9944 increases typical spike and wave discharges in WAG/Rij and Wistar rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Two types of electrocortical paroxysms in an inbred strain of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG/Rij rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Absence epilepsy and the level of vigilance in rats of the WAG/Rij strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Spike-wave discharges and sleep-wake states in rats with absence epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

GABAergic mechanisms in absence epilepsy: a computational model of absence epilepsy simulating spike and wave discharges after vigabatrin in WAG/Rij rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

The interaction between vigabatrin and diazepam on the electroencephalogram during active behaviour in rats: an isobolic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Effects of loreclezole on epileptic activity and on EEG and behaviour in rats with absence seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Direct activation of GABAA receptors by loreclezole, an anticonvulsant drug with selectivity for the beta-subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Termination of ongoing spike-wave discharges investigated by cortico-thalamic network analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Target-dependent control of synaptic inhibition by endocannabinoids in the thalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Global and focal aspects of absence epilepsy: the contribution of genetic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Reticular nucleus-specific changes in alpha3 subunit protein at GABA synapses in genetically epilepsy-prone rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Cannabinoids and Epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Frequency analysis of rat hippocampal electrical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Effects of acute δ9-THC administration on EEG and EEG power spectra in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Recent developments in cannabinoid ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

Antiepileptic and Prophylactic Effects of Tetrahydrocannabinols in Amygdaloid Kindled Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2019.106722

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2019.106722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31855784%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference